MAPT and Alzheimer disease: Current studies have clearly demonstrated that the p217-tau detected in blood is an excellent indicator of disease status, exhibiting high specificity and sensitivity to disease-related clinical changes [45], and enabling discrimination between AD and other NDDs [46].